90 related articles for article (PubMed ID: 2164206)
1. [Polychemotherapy of non-small cell bronchial cancer with mitomycin C, ifosfamide and vindesine].
Laumen R; Jungbluth H; von Pawel J; Häussinger K; Otto M; Krieger H
Pneumologie; 1990 Feb; 44 Suppl 1():590. PubMed ID: 2164206
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy of advanced non-small cell bronchial cancer with mitomycin C/ifosfamide versus mitomycin C/vindesine versus cisplatin/etoposide--a prospective randomized study].
Gatzemeier U; Heckmayr M; Hossfeld DK; Kaukel E; Koschel G; Neuhauss R
Pneumologie; 1990 Feb; 44 Suppl 1():258-60. PubMed ID: 2164194
[TBL] [Abstract][Full Text] [Related]
3. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
Fujii M; Kiura K; Okabe K; Toki H; Kimura M
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
[TBL] [Abstract][Full Text] [Related]
4. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
[TBL] [Abstract][Full Text] [Related]
5. European experience with ifosfamide in non-small cell lung cancer.
Drings P
Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer.
Soh LT; Tan EH; Ang PT
Singapore Med J; 1998 Aug; 39(8):357-8. PubMed ID: 9844496
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
Hayashi Y; Kato M; Matsuura T; Yamada Y; Adachi S; Ito G; Yamamoto K; Takeuchi T
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy with ifosfamide, mitomycin, and cisplatin in advanced non-small cell lung cancer.
Girón CG; Ordónez A; Jalón JI; Barón MG
Cancer Treat Rep; 1987 Sep; 71(9):851-3. PubMed ID: 3040245
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with bronchial arterial infusion (BAI) and systemic chemotherapy in advanced non-small cell lung cancer].
Houya I; Kimura I; Nagata M; Kuramitsu K; Kiuchi H; Sakamoto Y; Yamamoto K; Dohi Y; Kaneko K
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2697-700. PubMed ID: 2551216
[TBL] [Abstract][Full Text] [Related]
11. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
[TBL] [Abstract][Full Text] [Related]
12. Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group Study.
Miller TP; Vance RB; Ahmann FR; Rodney SR
Cancer Treat Rep; 1986 Sep; 70(9):1101-4. PubMed ID: 3527409
[TBL] [Abstract][Full Text] [Related]
13. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of primary resistant or recurrent small cell bronchial carcinoma with vindesine and ifosfamide].
Höfeler H; Höffken K; Niederle N; Schoetensack B; Wandl U; Kath R; Müller M; Schmidt CG
Dtsch Med Wochenschr; 1986 Dec; 111(51-52):1961-6. PubMed ID: 3024948
[TBL] [Abstract][Full Text] [Related]
15. A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.
Rosell R; Abad-Esteve A; Moreno I; Barnadas A; Carles J; Fernandez C; Ribelles N; Culubret M
Cancer; 1990 Apr; 65(8):1692-9. PubMed ID: 2156597
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer].
Fukuhara H; Oomura M; Sasaki H
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2469-72. PubMed ID: 2546507
[No Abstract] [Full Text] [Related]
17. [Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer].
Sato T; Mitsuhata N; Fujiwara K; Miyake M; Jyojya I; Ono T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):719-22. PubMed ID: 2451474
[No Abstract] [Full Text] [Related]
18. Radiotherapy alone versus chemotherapy with ifosfamide/vindesine followed by radiotherapy in unresectable locally advanced non-small cell lung cancer.
Wolf M; Hans K; Becker H; Hässler R; von Bültzingslöwen F; Goerg R; Klaasen HA; Dannhäuser J; Holle R; Pfab R
Semin Oncol; 1994 Jun; 21(3 Suppl 4):42-7. PubMed ID: 8209276
[TBL] [Abstract][Full Text] [Related]
19. [Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
Zhou CC; Zhang J; Zheng D; Lu MJ; Lu B; Xu JF
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):546-8. PubMed ID: 15388005
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the treatment of non-small cell lung cancer].
Sculier JP
Pathol Biol (Paris); 1992 Nov; 39(9):938-9. PubMed ID: 1311447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
